Zoek een klinische studie of trial
Andere zoekoptie(s)
17 Resultaat/Resultaten
Aanwerving proef
= 
; Lopend onderzoek
= 
; Gefinancierd door een IRDiRC-lid = 
Nationale klinische studie(s)
FRANKRIJK
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
A single-arm study to demonstrate the efficacy and safety of Privigen® in the treatment of subjects with chronic inflammatory demyelinating polyneuropathy (CIDP) (Phase III) - FR
Institution: Information not provided - FR
FRANKRIJK
ILE-DE-FRANCE
CRÉTEIL
SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study (Phase I-II)
CHU Henri Mondor
Service de neurologie
FRANKRIJK
ILE-DE-FRANCE
PARIS
MYCOPID : Does the Mycophenolate Improve the Ability of Weaning Patients Off the Treatment in Chronic Inflammatory Demyelinating Polyradiculopathy (CIDP) (Phase III)
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Explorations fonctionnelles neurologie
FRANKRIJK
NOUVELLE AQUITAINE
BORDEAUX
Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (Phase III) - FR
CHU - Hôpitaux de Bordeaux
Direction de la Recherche Clinique et de l'Innovation (DRCI) - Hôpitaux de Bordeaux
FRANKRIJK
PROVENCE-ALPES-COTE D'AZUR
NICE
A comparative, double-blind, randomised, multicentre efficacy and safety study of ClairYg® versus Tégéline® in maintenance treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (Phase III)
CHU de Nice - Hôpital Pasteur
Service Neurologie - Système Nerveux Périphérique, Muscle et SLA
ITALIË
LOMBARDIA
ROZZANO
PRISM 2 - International, multicentre, efficacy and safety study of I10E in the maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy: extension of PRISM study I10E-1302 (phase III) - IT
IRCCS Istituto Clinico Humanitas
Servizio di Diagnosi e Cura delle Polineuropatie
ITALIË
LOMBARDIA
ROZZANO
An international, multicentre, efficacy and safety study of I10E in initial and maintenance treatment of patients with chronic inflammatory demyelinating polyradiculoneuropathy (phase III) - IT
IRCCS Istituto Clinico Humanitas
Servizio di Diagnosi e Cura delle Polineuropatie
NEDERLAND
Noord-Holland
AMSTERDAM
Prednisolon versus Dexamethason in Chronische Inflammatoire Demyeliniserende Polyneuropathie (CIDP) trial
Amsterdam UMC, locatie AMC
Afdeling Neurologie
SPANJE
Cataluña
BARCELONA
Multicenter, open-label extension study to investigate the long-term safety and efficacy of IgPro20 in maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in subjects completing study IgPro20_3003 (Phase III) - ES (Completed)
Hospital Universitari Vall d'Hebron
Servicio de Neurología
SPANJE
Cataluña
BARCELONA
PRISM 2: International, multicentre, efficacy and safety study of I10E in the maintenance treatment of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Extension of PRISM study I10E-1302 (Phase III) - ES (Completed)
Hospital de la Santa Creu i Sant Pau
Servicio de Neurología
SPANJE
Cataluña
L'HOSPITALET DE LLOBREGAT
The PATH Study: Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investigate the efficacy, safety, and tolerability of 2 different doses of IgPro20 (s.c. Immunoglobulin) for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy - ES (completed)
Hospital Universitari de Bellvitge
Servicio de Neurología
SPANJE
Cataluña
L'HOSPITALET DE LLOBREGAT
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Fingolimod 0.5 mg Administered Orally Once Daily Versus Placebo in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (Phase III) - ES (Completed)
Hospital Universitari de Bellvitge
Servicio de Neurología
SPANJE
Comunidad Valenciana
VALENCIA
PRISM 2: International, multicentre, efficacy and safety study of I10E in the maintenance treatment of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Extension of PRISM study I10E-1302 (Phase III) - ES (Completed)
Hospital Universitario y Politécnico La Fe
Servicio de Neurología
SPANJE
Comunidad Valenciana
VALENCIA
PRISM: An international, multicentre, efficacy and safety study of I10E in initial and maintenance treatment of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (Phase III) - ES (completado)
Hospital Universitario y Politécnico La Fe
Servicio de Neurología
SPANJE
Comunidad Valenciana
VALENCIA
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) - ES
Hospital Universitario y Politécnico La Fe
Servicio de Neurología
VERENIGD KONINKRIJK
Greater Manchester
ADDRESS: NOT PROVIDED - UK
A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Fingolimod 0.5 mg Administered Orally Once Daily Versus Placebo in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (Phase III) - UK
Institution: Information not provided - UK
Multinationale klinische studie(s)
OOSTENRIJK
WIEN
ADDRESS: NOT PROVIDED - AT